Search

everythinglearnresearchcommunity

for

Search:↓

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

PCOS is a common condition in women that causes various symptoms and health issues, treatable with lifestyle changes and medication.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

People with lichen planus have higher bad cholesterol and lower good cholesterol, increasing their risk for heart disease.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

New drugs for heart disease may be developed from molecules secreted by stem cells.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Young adults with hair loss face higher risk of stiff arteries.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Gray hair is caused by reduced melanin production or transfer issues, linked to aging and possibly health conditions, with treatments focusing on color camouflage.

Severe hair loss links to metabolic issues in older men with psoriasis.

Women with PCOS have a higher risk of heart disease.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.